02Oct
Financial Daily Dose 10.2.2019 | Top Story: Johnson & Johnson Pays Out $20 Million to Avoid First Opioid Trial
Johnson & Johnson doled out $20 million to two Ohio counties rather than go through with its first federal opioid-related trial. The money is rather small potatoes for J&J, but it marks the “first time . . . the world’s largest maker of healthcare...
By:
Robins Kaplan LLP
Related
On February 2, 2021, the Federal Trade Commission (FTC), the agency charged with administering preme...
Read More >
FTI Consulting welcomes our clients and friends to the latest edition of the Activism Vulnerability ...
Read More >
NLRB Proposes Election Changes. On August 9, 2019, the National Labor Relations Board issued a notic...
Read More >
Financial Institutions M&A sector trends: Specialty finance/marketplace Lending — H1 2020 and outlo...
Read More >
Thomaston Acquisition, LLC v. Piedmont Construction Group, Inc., No. S19Q0249, 2019 BL 202176 (Ga. J...
Read More >
Recently, the National Labor Relations Board overruled portions of a 2001 decision and, as a practic...
Read More >